RMRobert A. Mook
Robert A. Mook
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert A. Mook has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Herbert Kim Lyerly
Department of Surgery, Division of Surgical Sciences, Duke University Medical Center
5 shared publications - Wei Chen
Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
5 shared publications Jiangbo Wang
Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
4 shared publicationsLarry S. Barak
Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, United States
4 shared publicationsXiu-Rong Ren
Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
3 shared publicationsHailan Piao
Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States
2 shared publications
Latest Publications
- 1 January 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (2) , 317-321
Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype
- 1 January 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (2) , 317-321
Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype
- 1 March 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 25 (6) , 1804-1816
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis
- 1 March 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 25 (6) , 1804-1816
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis
- 1 September 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (17) , 5829-5838
Structure–activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure
- 1 September 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (17) , 5829-5838
Structure–activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure
- 1 April 2013
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 23 (7) , 2187-2191
Small molecule modulators of Wnt/β-catenin signaling
- 1 April 2013
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 23 (7) , 2187-2191
Small molecule modulators of Wnt/β-catenin signaling
- 1 November 2012
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 20 (22) , 6751-6757
Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling
- 1 November 2012
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 20 (22) , 6751-6757
Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling